Dina Hertens

617 total citations
26 papers, 476 citations indexed

About

Dina Hertens is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dina Hertens has authored 26 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Dina Hertens's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (8 papers) and Breast Implant and Reconstruction (5 papers). Dina Hertens is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (8 papers) and Breast Implant and Reconstruction (5 papers). Dina Hertens collaborates with scholars based in Belgium, Italy and United States. Dina Hertens's co-authors include E. Vandeweyer, Jean‐Marie Nogaret, J.-M. Nogaret, Rika Deraemaecker, Michel Coibion, Isabelle Veys, Denis Larsimont, Ghizlane Rouas, Laurence Lespagnard and Marianne Paesmans and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Plastic & Reconstructive Surgery.

In The Last Decade

Dina Hertens

24 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Hertens Belgium 12 177 158 146 86 80 26 476
Fabinshy Thangarajah Germany 14 128 0.7× 139 0.9× 175 1.2× 58 0.7× 69 0.9× 49 512
LFAG Massuger Netherlands 6 126 0.7× 78 0.5× 113 0.8× 151 1.8× 71 0.9× 9 457
Antoni Pessarrodona Spain 12 207 1.2× 99 0.6× 124 0.8× 144 1.7× 15 0.2× 27 430
Sreekumar Sundara Rajan United Kingdom 9 107 0.6× 120 0.8× 144 1.0× 59 0.7× 23 0.3× 23 331
Zbigniew Kojs Poland 12 75 0.4× 66 0.4× 85 0.6× 48 0.6× 55 0.7× 70 453
Patricia C. Ewing‐Graham Netherlands 13 86 0.5× 192 1.2× 137 0.9× 43 0.5× 181 2.3× 39 528
W. Jäger Germany 13 78 0.4× 44 0.3× 172 1.2× 36 0.4× 29 0.4× 40 407
Iben Spanggaard Denmark 15 124 0.7× 85 0.5× 239 1.6× 49 0.6× 21 0.3× 43 561
Cosmin Moldovan Romania 9 198 1.1× 46 0.3× 173 1.2× 91 1.1× 30 0.4× 38 377
T. Rinda Soong United States 12 113 0.6× 41 0.3× 124 0.8× 69 0.8× 39 0.5× 35 475

Countries citing papers authored by Dina Hertens

Since Specialization
Citations

This map shows the geographic impact of Dina Hertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Hertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Hertens more than expected).

Fields of papers citing papers by Dina Hertens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Hertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Hertens. The network helps show where Dina Hertens may publish in the future.

Co-authorship network of co-authors of Dina Hertens

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Hertens. A scholar is included among the top collaborators of Dina Hertens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Hertens. Dina Hertens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belgrado, Jean-Paul, Sophie Vankerckhove, Véronique Feipel, et al.. (2017). Abstract P3-13-28: Lipofilling of the axilla to reduce secondary lymphedema after axillary lymph node dissection. Cancer Research. 77(4_Supplement). P3–13.
2.
Belgrado, Jean-Paul, Sophie Vankerckhove, Véronique Feipel, et al.. (2016). Lipofilling of the axilla to reduce secondary lymphedema after axillary lymph node dissection. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 17. 1 indexed citations
3.
Philippson, C., Stéphane Simon, Dina Hertens, et al.. (2014). Early Invasive Cancer and Partial Intraoperative Electron Radiation Therapy of the Breast: Experience of the Jules Bordet Institute. International Journal of Breast Cancer. 2014. 1–6. 11 indexed citations
5.
Veys, Isabelle, Virginie Durbecq, Samira Majjaj, et al.. (2009). Eighteen months clinical experience with the GeneSearch breast lymph node assay. The American Journal of Surgery. 198(2). 203–209. 18 indexed citations
6.
Veys, Isabelle, Samira Majjaj, Laurence Lespagnard, et al.. (2008). Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. European Journal of Surgical Oncology. 35(4). 387–392. 33 indexed citations
7.
Bourgeois, Patrice, Jean‐Marie Nogaret, Isabelle Veys, et al.. (2007). Isotope labelling and axillary node harvesting strategies for breast cancer. European Journal of Surgical Oncology. 34(6). 615–619. 4 indexed citations
8.
Philippson, C., et al.. (2006). Traitement par radio-chimiothérapie néoadjuvante et chirurgie du cancer du col utérin localement avancé. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 35(1). 23–27. 5 indexed citations
9.
Bourgeois, Patrice, Jean‐Marie Nogaret, Isabelle Veys, et al.. (2003). Sentinel lymph node imaging and research after bone scintigraphy in breast cancer patients. The Breast. 12(3). 194–202. 2 indexed citations
10.
Bourgeois, Pierre, J.-M. Nogaret, Isabelle Veys, et al.. (2003). How ‘hot’ is the pathologically positive sentinel lymph node in breast cancer patients?. Nuclear Medicine Communications. 24(5). 513–518. 18 indexed citations
11.
Renard, Françoise, et al.. (2002). Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. European Journal of Obstetrics & Gynecology and Reproductive Biology. 101(1). 58–63. 39 indexed citations
12.
Nogaret, Jean‐Marie, Dina Hertens, Isabelle Veys, Pierre Bourgeois, & Denis Larsimont. (2002). Ganglion sentinelle et cancer invasif du sein: vers une nouvelle approche chirurgicale minimaliste.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 23(3).
13.
Vandeweyer, E. & Dina Hertens. (2002). Quantification of glands and fat in breast tissue: An experimental determination. Annals of Anatomy - Anatomischer Anzeiger. 184(2). 181–184. 76 indexed citations
14.
Vandeweyer, E., Dina Hertens, Jean‐Marie Nogaret, & Rika Deraemaecker. (2001). Immediate Breast Reconstruction with SalineFilled Implants: No Interference with the Oncologic Outcome?. Plastic & Reconstructive Surgery. 107(6). 1409–1412. 47 indexed citations
15.
Hertens, Dina, et al.. (2001). Envahissement du ganglion sentinelle dans les cancers mammaires T0–T1. Annales de Chirurgie. 126(7). 654–658. 7 indexed citations
16.
Hertens, Dina, et al.. (2001). Mise au point : cancer du sein et grossesse.Revue de la littérature. Gynécologie Obstétrique & Fertilité. 29(1). 9–14. 11 indexed citations
17.
Renard, Françoise, et al.. (2000). Monitoring for endometrial disorders in 406 breast cancer women treated by tamoxifen. European Journal of Cancer. 36. 39–40. 1 indexed citations
18.
Gancberg, David, Laurence Lespagnard, Ghizlane Rouas, et al.. (2000). Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast Carcinomas. American Journal of Clinical Pathology. 113(5). 675–682. 81 indexed citations
19.
Veys, Isabelle, et al.. (1996). PP-2-18 breast cancer in women over 70. European Journal of Cancer. 32. 17–17. 2 indexed citations
20.
Coibion, Michel, et al.. (1994). Is there a role for cervicography in the detection of premalignant lesions of the cervix uteri?. British Journal of Cancer. 70(1). 125–128. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026